The United States is currently at an inflection point in Hepatitis C virus (HCV) response. We have the tools for rapid and accurate diagnosis, safe and effective cure, and prevention. These tools are only as useful as access to them can be, which is why the Cure Hepatitis C Act (S.1941) holds so much promise.
TAG and the Long-Acting Therapies Community Advisory Board (LAT CAB) welcomed a decision by the Indian Patent Office rejecting a patent application related to the hepatitis C treatment combination glecaprevir/pibrentasvir (G/P). Advocates say the decision could help reduce barriers to generic competition, lower treatment costs, and expand access to hepatitis C treatment in low- and middle-income countries disproportionately affected by the epidemic.
Treatment Action Group’s (TAG) HIV team works across the country to achieve a shared mission: end the HIV epidemic through science, policy, and advocacy. As a remote team, the reach is national but the urgency is personal. At a time when progress is possible and precarious, the team ensures that research translates into action for impacted communities.
TAG's leadership and staff broke down the latest in HIV, TB, and hepatitis C research and advocacy. See where the work stands and where it's headed.
CDC pauses rabies, mpox, and other infectious disease testing amid budget cuts and staffing losses, raising urgent public health concerns.
TAG recommends that the AIDS Research Advisory Council (ARAC) endorse NIAID's continued support of a balanced and comprehensive portfolio of basic, clinical, and implementation science — including a funding opportunity to renew its four current networks: the Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (ACTG), the International Maternal Pediatric Adolescent AIDS Clinical Trials Network (IMPAACT), the HIV Prevention Trials Network (HPTN), and the HIV Vaccine Trials Network (HVTN) or the updated IBPTN.
We're seeking a highly organized and technically proficient Administrator to support the organization as it continues to grow. This position reports to TAG’s Director of Finance. This is a full-time, salaried role.
TAG condemns the United States’ war in Iran and neighboring countries. At a time when U.S. investment in public health is being slashed, the Trump administration has chosen to spend billions of dollars per day on weapons used in a war of choice for which no credible rationale has been proposed. Our government should invest in our communities by spending funds that were already appropriated and illegally impounded by the White House Office of Management and Budget to keep people healthy, rather than starting new wars that put the entire world’s health at risk.
We are seeking a Research Intern to support our work advancing innovative financing strategies to accelerate tuberculosis (TB) research, development, and equitable access to lifesaving tools. In collaboration with the Senior TB Project Associate, the Research Intern will develop a research proposal and conduct research related to the relationship between the international financial architecture and investment and outcomes in TB.
We're seeking a dynamic, highly motivated, and organized Grant Officer to lead TAG's grant work and support fundraising efforts. Candidates should be grant professionals with a background in domestic and global public health research, practice, and advocacy, focused on expanding and maintaining TAG’s current grant portfolio. This is a full-time, salaried role.
Your donation will bring progress, healing, and hope — turning the promise of innovative research into a brighter, healthier future for all.
